Dermoscopy Tutorial Cover

New GenoMEL tutorial promoting dermoscopy
GenoMEL has created a new tutorial for clinicians. This tutorial is a basic introduction to dermoscopy and contains 100’s of images to help clinicians develop their diagnostic skill. Dermoscopy is a technique that improves the early recognition of melanoma. To view the tutorial please click the image above.

Dr Ruby Chang
Dr Ruby Chang, who led a major pooled data analysis for the GenoMEL consortium, has now left the University of Leeds to take up a post at the prestigious Royal Veternary College in London. Ruby has played a major role in numerous GenoMEL projects and led the writing of several GenoMEL papers. We wish her well in her new endeavours!

The ‘Predicting Benefit from Interferon Therapy in Melanoma’ study
GenoMEL’s Leeds team is conducting a study using information and samples from the following European interferon studies: AIM HIGH, EORTC 18952 and EORTC 18991. If you would like further information please see the main panel to the left.

Meetings in 2010

January
16-17 January, 20th Annual Cutaneous Malignancy Update, San Diego, USA

29 January, Melanoma Study Group, London, UK

June
17-19 June, 6th Congress of the European Association of Dermatologic Oncology (EADO), Athens, Greece

22-24 June, annual GenoMEL meeting, Leeds, UK

25 June, Melanoma Study Group, Leeds, UK

September
18-19 September, Perspectives in Melanoma XIV Amsterdam, The Netherlands

October
6-10 October, 19th EADV Congress, Gothenburg, Sweden

November
4-7 November, 7th Annual International Melanoma Research Congress & 4th Meeting of Interdisciplinary Melanoma/Skin Cancer Centers , Sydney, Australia

Meetings in 2011

Spring/early Summer
Annual GenoMEL meeting - Tel Aviv, Israel

If you have any comments on this news section, or on the website in general, please contact us at info@genomel.org

Dutch melanoma awareness leaflet

Initiative to raise public awareness of melanoma in the Netherlands
As part of a project supported by the GenoMEL Exchange Fund, our Leiden group has distributed 20,000 melanoma awareness leaflets to Dutch hospitals and family doctors. These colourful leaflets have proved extremely popular and point out the difference between melanomas (‘sharks’) and moles (‘dolphins’) in a non-threatening way.

Six month extension
The European Commission has granted GenoMEL a six month extension. The new end date for the grant period is the 31st May 2011.

The ‘Predicting Benefit from Interferon Therapy in Melanoma’ study
GenoMEL’s Leeds team is conducting a study using information and samples from the following European interferon studies: AIM HIGH, EORTC 18952 and EORTC 18991. If you would like further information please see the main panel to the left.

Meetings in 2009

November
1-4 November, SMR International Melanoma Congress, Boston, Massachusetts, USA

19-21 November, 3rd World meeting of interdisciplinary melanoma/skin cancer centres, Berlin, Germany

Meetings in 2010

January
16-17 January, 20th Annual Cutaneous Malignancy Update, San Diego, USA

June
17-19 June, 6th Congress of the European Association of Dermatologic Oncology (EADO), Athens, Greece

22-25 June, annual GenoMEL meeting, Leeds, UK

October
Early October, Perspectives in Melanoma XIV, Location TBC

6-10 October, 19th EADV Congress, Gothenburg, Sweden

November
4-7 November, 7th Annual International Melanoma Research Congress & 4th Meeting of Interdisciplinary Melanoma/Skin Cancer Centers , Sydney, Australia

Meetings in 2011

Spring/early Summer
Annual GenoMEL meeting - Tel Aviv, Israel

New JAAD paper
A new paper, led by Dr Sancy Leachman, has been published in the Journal of the American Academy of Dermatology (JAAD). Entitled, “Selection criteria for genetic assessment of patients with familial melanoma”, this consensus paper represents many months of consultation and detailed discussion.

The ‘Predicting Benefit from Interferon Therapy in Melanoma’ study
GenoMEL’s Leeds team is conducting a study using information and samples from the following European interferon studies: AIM HIGH, EORTC 18952 and EORTC 18991. If you would like further information please see the main panel to the left.

Meetings in 2009

October
7-11 October, 18th EADV Congress, Berlin, Germany

8-10 October, Perspectives in Melanoma XIII, Baltimore, USA

November
1-4 November, SMR International Melanoma Congress, Boston, Massachusetts, USA

19-21 November, 3rd World meeting of interdisciplinary melanoma/skin cancer centres, Berlin, Germany

Meetings in 2010

January
16-17 January, 20th Annual Cutaneous Malignancy Update, San Diego, USA

June
17-19 June, 6th Congress of the European Association of Dermatologic Oncology (EADO), Athens, Greece

22-25 June, annual GenoMEL meeting, Leeds, UK

October
Early October, Perspectives in Melanoma XIV, Location TBC

6-10 October, 19th EADV Congress, Gothenburg, Sweden

November
4-7 November, 7th Annual International Melanoma Research Congress & 4th Meeting of Interdisciplinary Melanoma/Skin Cancer Centers, Sydney, Australia

2011 GenoMEL Meeting
Prof. Esther Azizi will host the 2011 GenoMEL meeting in Tel Aviv, Israel.

New immunotherapy website
A new non-promotional website has been created by Bristol Myers Squibb dealing with the latest advances in immunotherapy in oncology (including melanoma). It is aimed at healthcare professionals and can be found here.

The ‘Predicting Benefit from Interferon Therapy in Melanoma’ study
GenoMEL’s Leeds team is conducting a study using information and samples from the following European interferon studies: AIM HIGH, EORTC 18952 and EORTC 18991. If you would like further information please see the main panel to the left.

Meetings in 2009

October
7-11 October, 18th EADV Congress, Berlin, Germany

8-10 October, Perspectives in Melanoma XIII, Baltimore, USA

November
1-4 November, SMR International Melanoma Congress, Boston, Massachusetts, USA

19-21 November, 3rd World meeting of interdisciplinary melanoma/skin cancer centres, Berlin, Germany

Meetings in 2010

January
16-17 January, 20th Annual Cutaneous Malignancy Update, San Diego, USA

June
17-19 June, 6th Congress of the European Association of Dermatologic Oncology (EADO), Athens, Greece

22-25 June, annual GenoMEL meeting, Leeds, UK

October
Early October, Perspectives in Melanoma XIV, Location TBC

6-10 October, 19th EADV Congress, Gothenburg, Sweden

November
4-7 November, 7th Annual International Melanoma Research Congress & 4th Meeting of Interdisciplinary Melanoma/Skin Cancer Centers, Sydney, Australia

Nature Genetics article
Nature Genetics have published a GenoMEL letter abstract entitled 'Genome-wide association study identifies three loci associated with melanoma risk'. This is a major achievement and a tribute to the hard work of everyone involved.

The Queen’s Birthday List
GenoMEL member Professor Richard Kefford was recently made a member of the Order of Australia. Professor Kefford, the Director of the Westmead Institute for Cancer Research in Sydney, was given the award for service to medicine. Congratulations!

The ‘Predicting Benefit from Interferon Therapy in Melanoma’ study
GenoMEL’s Leeds team is conducting a study using information and samples from the following European interferon studies: AIM HIGH, EORTC 18952 and EORTC 18991. If you would like further information please see the main panel to the left.

Questionnaires for existing GenoMEL study participants
Two online questionnaires are available for people who have already been involved in our melanoma family studies. To take part you need a password from your research group. To find the questionnaires please click here.

Meetings in 2009

October
7-11 October, 18th EADV Congress, Berlin, Germany

November
1-4 November, SMR International Melanoma Congress, Boston, Massachusetts, USA

4-6 November, Perspectives in Melanoma XIII, Baltimore, USA

Meetings in 2010

January
16-17 January, 20th Annual Cutaneous Malignancy Update, San Diego, USA

June
22-25 June, annual GenoMEL meeting, Leeds, UK

October
Early October, Perspectives in Melanoma XIV, Location TBC

6-10 October, 19th EADV Congress, Gothenburg, Sweden

November
7th Annual International Melanoma Research Congress & 4th Meeting of Interdisciplinary Melanoma/Skin Cancer Centers, Sydney, Australia

Annual GenoMEL meetings
Last month the 2009 GenoMEL meeting took place in Ljubljana, Slovenia. Both the hospitality of our Slovenian hosts and the beauty of their country impressed everyone. The 2010 meeting will be in Leeds 22-25 June.

The ‘Predicting Benefit from Interferon Therapy in Melanoma’ study
GenoMEL’s Leeds team is conducting a study using information and samples from the following European interferon studies: AIM HIGH, EORTC 18952 and EORTC 18991. If you would like further information please see the main panel to the left.

Questionnaires for existing GenoMEL study participants
Two online questionnaires are available for people who have already been involved in our melanoma family studies. To take part you need a password from your research group. To find the questionnaires please click here.

Meetings in 2009

July
7-10 July, British Association of Dermatologists Annual Meeting, Glasgow, UK

October
7-11 October, 18th EADV Congress, Berlin, Germany

November
1-4 November, SMR International Melanoma Congress, Boston, Massachusetts, USA

4-6 November, Perspectives in Melanoma XIII, Baltimore, USA

The recent World Congress on Melanoma
Last month the 7th World Congress on Melanoma took place in combination with the 5th Congress of the European Association of Dermato-Oncology in Vienna. Numerous members of GenoMEL were involved as session chairs and speakers.

The ‘Predicting Benefit from Interferon Therapy in Melanoma’ study
GenoMEL’s Leeds team is conducting a study using information and samples from the following European interferon studies: AIM HIGH, EORTC 18952 and EORTC 18991. If you would like further information please see the main panel to the left.

Questionnaires for existing GenoMEL study participants
Two online questionnaires are available for people who have already been involved in our melanoma family studies. To take part you need a password from your research group. To find the questionnaires please click here.

Meetings in 2009

June
9-12 June, Annual GenoMEL Meeting, Ljubljana, Slovenia

July
7-10 July, British Association of Dermatologists Annual Meeting, Glasgow, UK

October
7-11 October, 18th EADV Congress, Berlin, Germany

November
1-4 November, SMR International Melanoma Congress, Boston, Massachusetts, USA

4-6 November, Perspectives in Melanoma XIII, Baltimore, USA

Registration deadline for the GenoMEL annual meeting
Registration for the 2009 summer meeting closes on the 7th May! GenoMEL members should have received instructions on how to register – if you have any queries please email info@genomel.org.

The ‘Predicting Benefit from Interferon Therapy in Melanoma’ study
GenoMEL’s Leeds team is conducting a study using information and samples from the following European interferon studies: AIM HIGH, EORTC 18952 and EORTC 18991. If you would like further information please see the main panel to the left.

Questionnaires for existing GenoMEL study participants
Two online questionnaires are available for people who have already been involved in our melanoma family studies. To take part you need a password from your research group. To find the questionnaires please click here.

Meetings in 2009

May
3-6 May, 12th World Congress on Cancers of the Skin, Tel Aviv, Israel

12-16 May, 7th World Congress on Melanoma, joint meeting with the 5th Congress of the European Association of Dermato-Oncology Vienna, Austria

20-24 May, 10th International Congress of Dermatology, Prague, Czech Republic

June
9-12 June, Annual GenoMEL Meeting, Ljubljana, Slovenia

July
7-10 July, British Association of Dermatologists Annual Meeting, Glasgow, UK

October
7-11 October, 18th EADV Congress, Berlin, Germany

November
1-4 November, SMR International Melanoma Congress, Boston, Massachusetts, USA

4-6 November, Perspectives in Melanoma XIII, Baltimore, USA

New tutorial for clinicians
GenoMEL has produced an online tutorial to assist clinicians in the early diagnosis of melanoma. This interactive package, containing text, pictures and videos, is available here.

New paper
There is a paper this month in the Journal of Medical Ethics that draws on the consortium’s experiences of dealing with genetic research test results. The author, Paul Affleck, is one of GenoMEL’s project managers. Further details are available here.

The ‘Predicting Benefit from Interferon Therapy in Melanoma’ study
GenoMEL’s Leeds team is conducting a study using information and samples from the following European interferon studies: AIM HIGH, EORTC 18952 and EORTC 18991. See main panel on left.

Questionnaires for existing GenoMEL study participants
Two online questionnaires are available for people who have already been involved in our melanoma family studies. To take part you need a password from your research group. To find the questionnaires please click here.

Meetings in 2009

May
3-6 May, 12th World Congress on Cancers of the Skin, Tel Aviv, Israel

12-16 May, 7th World Congress on Melanoma, joint meeting with the 5th Congress of the European Association of Dermato-Oncology Vienna, Austria

20-24 May, 10th International Congress of Dermatology, Prague, Czech Republic

June
9-12 June, Annual GenoMEL Meeting, Ljubljana, Slovenia

October
7-11 October, 18th EADV Congress, Berlin, Germany

November
1-4 November, SMR International Melanoma Congress, Boston, Massachusetts, USA

4-6 November, Perspectives in Melanoma XIII, Baltimore, USA

Dr Yu-mei (Ruby) Chang

New GenoMEL paper
The International Journal of Cancer has published a new GenoMEL paper entitled 'A pooled analysis of Melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes'. This paper describes a pooled analysis using naevus data from 15 case-control studies, involving over 10,000 individuals. Dr Yu-mei Chang led this work on behalf of GenoMEL.

The ‘Predicting Benefit from Interferon Therapy in Melanoma’ study
GenoMEL’s Leeds team is conducting a study using information and samples from the following European interferon studies: AIM HIGH, EORTC 18952 and EORTC 18991. See main panel on left.

Questionnaires for existing GenoMEL study participants
Two online questionnaires are available for people who have already been involved in our melanoma family studies. To take part you need a password from your research group. To find the questionnaires please click here.

Meetings in 2009

May
3-6 May, 12th World Congress on Cancers of the Skin, Tel Aviv, Israel

12-16 May, 7th World Congress on Melanoma, joint meeting with the 5th Congress of the European Association of Dermato-Oncology Vienna, Austria

20-24 May, 10th International Congress of Dermatology, Prague, Czech Republic

June
9-12 June, Annual GenoMEL Meeting, Ljubljana, Slovenia

October
7-11 October, 18th EADV Congress, Berlin, Germany

November
1-4 November, SMR International Melanoma Congress, Boston, Massachusetts, USA

4-6 November, Perspectives in Melanoma XIII, Baltimore, USA

Congratulations to Professor Wilma Bergman!
A senior member of our LUMC group has received a professorship in recognition of her sterling work.

The ‘Predicting Benefit from Interferon Therapy in Melanoma’ study
GenoMEL’s Leeds team is conducting a study using information and samples from the following European interferon studies: AIM HIGH, EORTC 18952 and EORTC 18991. See main panel on left.

The GenoMEL early diagnosis of melanoma tutorial
NKD, one of the GenoMEL partners, are putting the final changes to the GenoMEL tutorial concerning the early diagnosis of melanoma. The tutorial is due to be mounted on the website in early 2009. Further announcements will follow.

Questionnaires for existing GenoMEL study participants
Two online questionnaires are available for people who have already been involved in our melanoma family studies. To take part you need a password from your research group. To find the questionnaires please click here.

Meetings in 2009

March
6-10 March, 67th Annual Meeting of the AAD, San Francisco, California, USA

May
3-6 May, 12th World Congress on Cancers of the Skin, Tel Aviv, Israel

12-16 May, 7th World Congress on Melanoma, joint meeting with the 5th Congress of the European Association of Dermato-Oncology Vienna, Austria

20-24 May, 10th International Congress of Dermatology, Prague, Czech Republic

June
9-12 June, Annual GenoMEL Meeting, Ljubljana, Slovenia

October
7-11 October, 18th EADV Congress, Berlin, Germany

November
1-4 November, SMR International Melanoma Congress, Boston, Massachusetts, USA

4-6 November, Perspectives in Melanoma XIII, Baltimore, USA

If you have any comments on the website or on this news section please e-mail us at info@genomel.org

Congratulations to Professor Esther Azizi!
The leader of GenoMEL’s Israeli group has received a Professorship in recognition of her sterling work.

The ‘Predicting Benefit from Interferon Therapy in Melanoma’ study
GenoMEL’s Leeds team is conducting a study using information and samples from the following European interferon studies: AIM HIGH, EORTC 18952 and EORTC 18991. See main panel on left.

The GenoMEL early diagnosis of melanoma tutorial
NKD, one of the GenoMEL partners, are putting the final changes to the GenoMEL tutorial concerning the early diagnosis of melanoma. The tutorial is due to be mounted on the website in early 2009. Further announcements will follow.

New questionnaires for existing GenoMEL study participants
Two online questionnaires are now available for people who have already been involved in our melanoma family studies. To take part you need a password from your research group. To find the questionnaires please click here.

Meetings in 2009

January
24-25 January, 19th Annual Cutaneous Malignancy Update, San Diego, California

30 January, Melanoma Study Group, UCL, London, UK

March
6-10 March, 67th Annual Meeting of the AAD, San Francisco, California, USA

May
3-6 May, 12th World Congress on Cancers of the Skin, Tel Aviv, Israel

12-16 May, 7th World Congress on Melanoma, joint meeting with the 5th Congress of the European Association of Dermato-Oncology Vienna, Austria

20-24 May, 10th International Congress of Dermatology, Prague, Czech Republic

June
9-12 June, Annual GenoMEL Meeting, Ljubljana, Slovenia

October
7-11 October, 18th EADV Congress, Berlin, Germany

November
1-4 November, SMR International Melanoma Congress, Boston, Massachusetts, USA

Congratulations to Professor Esther Azizi!
The leader of GenoMEL’s Israeli group has received a Professorship in recognition of her sterling work.

The ‘Predicting Benefit from Interferon Therapy in Melanoma’ study
GenoMEL’s Leeds team is conducting a study using information and samples from the following European interferon studies: AIM HIGH, EORTC 18952 and EORTC 18991. See main panel on left.

The GenoMEL early diagnosis of melanoma tutorial
NKD, one of the GenoMEL partners, are putting the final changes to the GenoMEL tutorial concerning the early diagnosis of melanoma. The tutorial is due to be mounted on the website in early 2009. Further announcements will follow.

New questionnaires for existing GenoMEL study participants
Two online questionnaires are now available for people who have already been involved in our melanoma family studies. To take part you need a password from your research group. To find the questionnaires please click here.

Meetings in 2009

January
24-25 January, 19th Annual Cutaneous Malignancy Update, San Diego, California

30 January, Melanoma Study Group, UCL, London, UK

March
6-10 March, 67th Annual Meeting of the AAD, San Francisco, California, USA

May
3-6 May, 12th World Congress on Cancers of the Skin, Tel Aviv, Israel

12-16 May, 7th World Congress on Melanoma, joint meeting with the 5th Congress of the European Association of Dermato-Oncology Vienna, Austria

20-24 May, 10th International Congress of Dermatology, Prague, Czech Republic

June
9-12 June, Annual GenoMEL Meeting, Ljubljana, Slovenia

October
7-11 October, 18th EADV Congress, Berlin, Germany

November
1-4 November, SMR International Melanoma Congress, Boston, Massachusetts, USA